EvolveImmune Therapeutics logo

EvolveImmune Therapeutics

Reimagining Cancer Immunotherapy

58 employees · est. 2020 · Branford, United States

VS
Thunder Biotech logo

Thunder Biotech

MOTO-CAR®s: Innovative macrophage technology designed to provide effective treatment for patients with solid tumors.

15 employees · est. 2016 · Provo, United States

Thunder Biotech is the older company (2020 vs 2016); EvolveImmune Therapeutics is the larger of the two.

Side-by-Side Comparison

EvolveImmune Therapeutics Thunder Biotech
Founded
2020 2016 older
Headquarters
Branford, United States Provo, United States
Employees
58 larger 15
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Pharmaceutical
Funding Stage
Series Unknown Debt Financing
Total Funding
$54.95M $24.51M
Funding Rounds
2 6
Services
Development of trispecific T cell engagers, Partnerships for additional therapeutic development, Clinical trial management Not tracked yet
Target Customers
Cancer patients, Healthcare institutions, Pharmaceutical companies Not tracked yet
Taxonomy
Cancer Immunotherapy, Trispecific T Cell Engagers, CD2 Costimulation, EVOLVE Platform, Tumor Cell Resistance, Clinical Trials, Immune Activation, Tumor Targeting, Cytokine Secretion Amplification, Biotherapeutics Engineering, CD3 Bispecific Limitations, Immune Therapy Optimization, T-Cell Exhaustion, Immunobiological Platform, Tumor Cell Killing Immune-oncology, MOTO-CAR Technology, Solid Tumors, Cancer Treatment, Genetic Engineering, CAR Macrophages, Tumor Associated Macrophages, T Cell Response, Tumor Cell Destruction, Immunotherapy, Tumor Recurrence Prevention
Website
evolveimmune.com thunderbiotech.com
EvolveImmune Therapeutics logo

About EvolveImmune Therapeutics

EvolveImmune Therapeutics, founded in 2020 and headquartered in the United States, is a biotechnology company creating innovative solutions for cancer treatment. Their slogan, "Reimagining Cancer Immunotherapy", reflects their ambitious approach in developing unique trispecific T cell engagers via t...

Thunder Biotech logo

About Thunder Biotech

Thunder Biotech is a biotechnology and pharmaceutical company based in the United States, founded in 2016. The company's flagship product, MOTO-CAR®, is an innovative macrophage technology designed to provide effective treatment for patients with solid tumors. Thunder Biotech is focused on developin...

We will tell you when either one moves

BounceWatch watches EvolveImmune Therapeutics and Thunder Biotech for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at EvolveImmune Therapeut... and Thunder Biotech — by email.

Frequently Asked Questions

EvolveImmune Therapeutics — Reimagining Cancer Immunotherapy. Thunder Biotech — MOTO-CAR®s: Innovative macrophage technology designed to provide effective treatment for patients with solid tumors.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
EvolveImmune Therapeutics has raised $54.95M while Thunder Biotech has raised $24.51M.
EvolveImmune Therapeutics and Thunder Biotech operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare EvolveImmune Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at EvolveImmune Therapeutics on 15 Jun 2026, and Thunder Biotech on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy